Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-12-30 4:11 pm Sale | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 4,631,432 4.6% | -2,000,000 (-30.16%) | View |
| 2022-02-14 09:08 am Sale | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Sonic Fund II L.P. | 2,469,880 9.5% | -25,873 (-1.04%) | View |
| 2021-04-16 3:11 pm Unchanged | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 6,631,432 6.8% | 0 (Unchanged) | View |
| 2021-04-09 4:54 pm Purchase | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 6,631,432 6.8% | 500,000 (+8.15%) | View |
| 2021-03-18 2:21 pm Purchase | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 6,131,432 6.3% | 915,281 (+17.55%) | View |
| 2021-02-16 3:46 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 5,216,151 5.4% | 968,870 (+22.81%) | View |
| 2021-02-16 3:44 pm Purchase | 13G | FENNEC PHARMACEUTICALS, INC. O FENC | Sonic Fund II L.P. | 2,495,753 9.7% | 2,495,753 (New Position) | View |
| 2020-08-20 2:21 pm Purchase | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 4,247,281 4.4% | 451,715 (+11.90%) | View |
| 2019-05-03 4:21 pm Purchase | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Sonic Fund II L.P. | 3,795,566 6% | 300,000 (+8.58%) | View |